Another Lead-212 plant for Areva

19 April 2016

Areva Med, the subsidiary of French engineering company Areva for the development of cancer treatments, opened its second lead-212 production facility on 15 April. The plant in Plano, Texas, known as DDPU (Domestic Distribution and Purification Unit), will be Areva Med's US. It will also host the laboratories and offices of its subsidiary, Macrocyclics, which designs and manufactures chelating agents and chemicals for nuclear medicine.

An Areva Med statement said the new facility will employ ten people and represents an opportunity to "expand the range and increase the quality of products and services for its American partners and customers".

Areva in February 2014 announced the selection of Caen in northwest France as the location for its planned industrial-scale lead-212 production facility. It said that Areva Med plans to build the plant to "provide an industrial production capacity" to complement the Maurice Tubiana facility in Bessines in western France. The Maurice Tubiana facility, opened in November 2013, recovers high-purity lead-212 from thorium-232 and produces sufficient amounts for clinical development.

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.